The antibiotic viscosin, a cyclic depsipeptide isolated from Pseudomas viscosa, shows promising in vitro and in vivo (mice) cytotoxicity against Trypanosoma cruzi, the causative agent in Chagas' disease. The total synthesis of viscosin is proposed in order to confirm the chemical structure and provide material for research. The methods developed in this synthesis will be useful for future syntheses of fragments and analogs necessary to determine the structure-activity relationships of the compound. Viscosin and related compounds represent a class of potential chemotherapeutic agents for Chagas' disease which at present is an incurable and potentially fatal disease affecting millions of people.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43AI023571-01
Application #
3488474
Study Section
Biophysics and Biophysical Chemistry A Study Section (BBCA)
Project Start
1986-03-01
Project End
1986-08-31
Budget Start
1986-03-01
Budget End
1986-08-31
Support Year
1
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Peptide Technologies Corporation
Department
Type
DUNS #
City
Gaithersburg
State
MD
Country
United States
Zip Code
20877